On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Rolf A. Stahel

ResearcherPublications, citations & collaboration network

Rolf A. Stahel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Rolf A. Stahel have?

ScholarIQindexed works

Rolf A. Stahel has 547 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Rolf A. Stahel have?

ScholarIQcitation count

Rolf A. Stahel has 29,247 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Rolf A. Stahel?

ScholarIQh-index

Rolf A. Stahel has an h-index of 85 in OpenAlex.

What is the i10-index of Rolf A. Stahel?

ScholarIQi10-index

Rolf A. Stahel has an i10-index of 284 in OpenAlex.

What is the ORCID of Rolf A. Stahel?

ScholarIQorcid

The ORCID for Rolf A. Stahel is on the source record.

What is the OpenAlex record for Rolf A. Stahel?

ScholarIQopenalex

The OpenAlex for Rolf A. Stahel is on the source record.

What are the most-cited papers on Rolf A. Stahel?

ScholarIQmost cited works
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
Johan Vansteenkiste, Lucio Crinò, Christophe Dooms, Jean-Yves Douillard, Corinne Faivre‐Finn, Eric Lim, Gaetano Rocco, Suresh Senan, Paul Van Schil, Paolo Veronesi, Rolf A. Stahel, Solange Peters, Enriqueta Felip, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Paolo Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, W. Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel
Annals of Oncology. 2014497 CitationsOPEN ACCESS
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos, Thomas Bachelot, Rina Hui, Giuseppe Curigliano, Mario Campone, Laura Biganzoli, Hervé Bonnefoi, Guy Jérusalem, Rupert Bartsch, Manuela Rabaglio, Roswitha Kammler, Rudolf Maibach, Mark J. Smyth, Angelo Di Leo, Marco Colleoni, Giuseppe Viale, Meredith M. Regan, Fabrice André, Debora Fumagalli, Richard D. Gelber, Theodora Goulioti, Anita Hiltbrunner, Rita L. Hui, Heidi Roschitzki, Barbara Ruepp, Frances M. Boyle, Rolf A. Stahel, Stefan Aebi, Alan S. Coates, Aron Goldhirsch, Per Karlsson, Ingrid Kössler, Stamatina Fournarakou, Adriana Gasca, Rita Pfister, Sabrina Ribeli-Hofmann, Magdelena Weber, Daniela Celotto, Carmen Comune, M. Frapolli, Magdalena Sánchez-Hohl, Hui Huang, Caitlin Mahoney, Karen N. Price, Karolyn Scott, Holly Shaw, Susan M. Fischer, Mónica Greco, Colleen King, Stefania Andrighetto, Martine Piccart, Heather E. Findlay, Michelle Jenkins, Vassiliki Karantza, Jaime Mejia, Patrick Schneier
The Lancet Oncology. 2019481 Citations
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
K.M. Kerr, L. Bubendorf, Martin J. Edelman, Andrea Ascoli Marchetti, Tony Mok, Silvia Novello, Kenneth J. O’Byrne, Rolf A. Stahel, Solange Peters, Enriqueta Felip, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, W. Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel
Annals of Oncology. 2014300 CitationsOPEN ACCESS
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
Solange Peters, Rolf A. Stahel, Lukas Bubendorf, Philip Bonomi, Augusto Villegas, Dariusz M. Kowalski, Christina S. Baik, Dolores Isla, Javier de Castro, Pilar Garrido, Achim Rittmeyer, Marcello Tiseo, Christoph Meyenberg, Sanne de Haas, Lisa H. Lam, Michael W. Lu, Thomas E. Stinchcombe
Clinical Cancer Research. 2018231 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account